News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tuberculosis Diagnostics Firm Oxford Immunotec Limited Files for $86 Million IPO


10/16/2013 8:24:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Oxford Immunotec Global, which sells diagnostic tests for latent Tuberculosis infection, filed on Tuesday with the SEC to raise up to $86 million in an initial public offering. The Abingdon, United Kingdom-based company, which was founded in 2002 and booked $29 million in sales for the 12 months ended June 30, 2013, plans to list on the NASDAQ under the symbol OXFD. Oxford Immunotec Global initially filed confidentially on September 10, 2013. J.P. Morgan and Piper Jaffray are the joint bookrunners on the deal. No pricing terms were disclosed.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES